Showing results (781-790 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|May 24, 2001
Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrateC Kyrklund, J T Backman, K T Kivistö, et al.Clinical Pharmacology and Therapeutics|April 20, 2001
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactionsK Fattinger, C Funk, M Pantze, et al.Clinical Pharmacology and Therapeutics|January 1, 1975
Blood flow in muscle groups and drug absorptionE F Evans, J D Proctor, M J Fratkin, et al.Clinical Pharmacology and Therapeutics|April 1, 1975
Determinants of the renal clearance of digoxinH Halkin, L B Sheiner, C C Peck, et al.Clinical Pharmacology and Therapeutics|June 1, 1975
Unaltered metabolism of antipyrine and tolbutamide in fasting manM M Reidenberg, E S VesellClinical Pharmacology and Therapeutics|June 1, 1975
Carbenicillin therapy in patients with normal and impaired renal functionD L Latos, C S Bryan, W J StoneClinical Pharmacology and Therapeutics|September 15, 2001
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycinK S Yu, J Y Cho, J H Shon, et al.Clinical Pharmacology and Therapeutics|September 15, 2001
Lack of effect of reboxetine on cardiac repolarizationJ C Fleishaker, S F Francom, B D Herman, et al.Clinical Pharmacology and Therapeutics|November 1, 1975
Commentary: Patient package inserts. I. Nature, notions, and needsP Joubert, L LasagnaClinical Pharmacology and Therapeutics|January 28, 2021
Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal OutcomeOlivier Collignon, Carl-Fredrik Burman, Martin Posch, et al.Pageof 941